Minerva Imaging is a scientifically driven CRO focussed on targeted radionuclide therapy with the use of advanced oncology models and molecular imaging for translational cancer research and drug development.
With over 10 years of experience in targeted radionuclide therapy, we are experts in designing and performing preclinical targeted radionuclide therapy studies. We operate a facility with on-site radiochemistry and vivarium for small and large animals equipped with molecular imaging systems. We are licensed to work with relevant isotopes for targeted radionuclide therapy and diagnostics.
We engage with our clients to understand their scientific questions and discuss how our methods and capabilities can provide answers. Our competences build on more than two decades of research within oncology, targeted radionuclide therapy and molecular imaging performed at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.
Visit our website for more informaion: www.minervaimaging.com Or follow us on LinkedIn to stay up-to-date: https://www.linkedin.com/company/minerva-imaging
Brands: Minerva Imaging is a scientifically driven CRO focussed on targeted radionuclide therapy with the use of advanced oncology models and molecular imaging for translational research and drug development.